Publikationen in Zusammenarbeit mit Forschern von University of Pennsylvania (8)

2024

  1. Endovascular Thrombectomy Treatment Effect in Direct vs Transferred Patients with Large Ischemic Strokes: A Prespecified Analysis of the SELECT2 Trial

    JAMA Neurology, Vol. 81, Núm. 4, pp. 327-335

  2. Endovascular Thrombectomy for Large Ischemic Stroke Across Ischemic Injury and Penumbra Profiles

    JAMA, Vol. 331, Núm. 9, pp. 750-763

  3. Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke: 1-year outcomes of the SELECT2 trial

    The Lancet, Vol. 403, Núm. 10428, pp. 731-740

2023

  1. Trial of Endovascular Thrombectomy for Large Ischemic Strokes.

    New England Journal of Medicine, Vol. 388, Núm. 14, pp. 1259-1271

2022

  1. Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders

    The Lancet Neurology, Vol. 21, Núm. 10, pp. 899-910

  2. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  3. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2018

  1. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

    The Lancet Neurology, Vol. 17, Núm. 12, pp. 1053-1060